Results for tag: "Carfilzomib"

Carfilzomib is a proteasome inhibitor used to treat multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is used in combination with other drugs, such as dexamethasone, to treat relapsed or refractory multiple myeloma. Carfilzomib is also used to treat other types of leukemia, such as chronic lymphocytic leukemia and acute myeloid leukemia. It is administered intravenously and is available in both oral and intravenous formulations. Carfilzomib is a relatively new drug in the leukemia drug market, but it has been gaining traction due to its efficacy in treating multiple myeloma. It has been approved by the US Food and Drug Administration (FDA) for the treatment of multiple myeloma and is currently being studied for its potential use in other types of leukemia. Some of the companies in the Carfilzomib market include Amgen, Onyx Pharmaceuticals, and Takeda Pharmaceuticals. Amgen is the manufacturer of the drug, while Onyx Pharmaceuticals and Takeda Pharmaceuticals are the two companies that market and distribute the drug. Show Less Read more